Skip to content

Clinical comprehensive evaluation of traditional Chinese medicine acupoint application in children with acute upper respiratory tract infection

Clinical comprehensive evaluation of traditional Chinese medicine acupoint application in children with acute upper respiratory tract infection

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000694
Enrollment
Unknown
Registered
2026-03-24
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute upper respiratory tract infection

Interventions

Xiao Er Chai Gui Tui Re Granules:Xiao Er Chai Gui Tui Re Granules
Xiao Er Niu Huang Tui Re Tie:Xiao Er Niu Huang Tui Re Tie

Sponsors

Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1: who meet the diagnostic criteria for acute upper respiratory tract infection in children and whose syndrome in traditional Chinese medicine is classified as wind-heat syndrome 2: 1 - 5 years old 3: no gender limitation 4: the body temperature (taken under the armpit) was greater than 37.2°C but less than or equal to 38.5°C 5: Peripheral blood WBC and neutrophil classification = upper limit of reference value 6: The patient and his/her guardian are willing to follow the procedures and operations stipulated in the research protocol 7: The guardian of the patient is willing and able to provide written informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1: Infectious diseases such as herpangina, pharyngoconjunctivitis, and suppurative tonsillitis, as well as infectious diseases 2: Those with combined tracheitis and bronchitis; those with severe diseases in the systems such as heart, brain, lungs, liver, kidneys and hematopoiesis 3: who have used drugs or undergone other treatments that affect body temperature within the previous 4 hours 4: There are relevant drug contraindications 5: It is known that the subjects are allergic to the research drug or its components 6: The researchers believe that the condition of the child might interfere with participation in the study or other activities that are not suitable for him/her

Design outcomes

Primary

MeasureTime frame
Onset time of fever reduction;

Secondary

MeasureTime frame
The complete temperature reduction rate 4 hours after medication administration;The complete temperature reduction rate 8 hours after medication administration;The changes in body temperature of the subjects within 8 hours after medication administration;Rescue medication usage;Adverse Event Incidence Rate;

Countries

China

Contacts

Public ContactWu Juan

Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University

wujuan_0207@163.com18918397709

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026